Effectiveness of first and second COVID-19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021-July 2022.

MLA

Petrie, Joshua G., et al. “Effectiveness of First and Second COVID-19 MRNA Vaccine Monovalent Booster Doses during a Period of Circulation of Omicron Variant Sublineages: December 2021-July 2022.” Influenza and Other Respiratory Viruses, vol. 17, no. 3, Mar. 2023, p. e13104. EBSCOhost, https://doi.org/10.1111/irv.13104.

APA

Petrie, J. G., King, J. P., McClure, D. L., Rolfes, M. A., Meece, J. K., Pattinson, D., Neumann, G., Kawaoka, Y., Belongia, E. A., & McLean, H. Q. (2023). Effectiveness of first and second COVID-19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021-July 2022. Influenza and Other Respiratory Viruses, 17(3), e13104. https://doi.org/10.1111/irv.13104

Chicago

Petrie, Joshua G, Jennifer P King, David L McClure, Melissa A Rolfes, Jennifer K Meece, David Pattinson, Gabriele Neumann, Yoshihiro Kawaoka, Edward A Belongia, and Huong Q McLean. 2023. “Effectiveness of First and Second COVID-19 MRNA Vaccine Monovalent Booster Doses during a Period of Circulation of Omicron Variant Sublineages: December 2021-July 2022.” Influenza and Other Respiratory Viruses 17 (3): e13104. doi:10.1111/irv.13104.